Monopar Therapeutics (MNPR) Free Cash Flow (2017 - 2025)

Quarterly results put Free Cash Flow at -$3.4 million for Q4 2025, down 68.64% from a year ago — trailing twelve months through Dec 2025 was -$12.2 million (down 90.52% YoY), and the annual figure for FY2025 was -$12.2 million, down 90.52%.

Monopar Therapeutics has reported Free Cash Flow over the past 9 years, most recently at -$3.4 million for Q4 2025.

  • Free Cash Flow reached -$3.4 million in Q4 2025 per MNPR's latest filing, down from -$2.1 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at -$1.1 million in Q3 2024 and bottomed at -$5.7 million in Q1 2025.
  • Median Free Cash Flow over the past 5 years was -$1.9 million (2021), compared with a mean of -$2.1 million.
  • The largest annual shift saw Free Cash Flow skyrocketed 44.66% in 2024 before it tumbled 242.11% in 2025.
  • Over 5 years, Free Cash Flow stood at -$2.0 million in 2021, then surged by 35.93% to -$1.3 million in 2022, then fell by 18.75% to -$1.5 million in 2023, then dropped by 29.27% to -$2.0 million in 2024, then tumbled by 68.64% to -$3.4 million in 2025.
  • Business Quant data shows Free Cash Flow for MNPR at -$3.4 million in Q4 2025, -$2.1 million in Q3 2025, and -$1.1 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - -1.67 Mn
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn -12.20 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -2.49 Mn
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 1.29 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 848.30 Mn
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 48.67 Mn
10 Monopar Therapeutics 466.82 Mn 466.82 Mn - -3.37 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -3.37 Mn
Dec 31, 2025 -3.37 Mn
Sep 30, 2025 -2.09 Mn
Sep 30, 2025 -2.09 Mn
Jun 30, 2025 -1.08 Mn
Jun 30, 2025 -1.08 Mn
Mar 31, 2025 -5.66 Mn
Mar 31, 2025 -5.66 Mn
Dec 31, 2024 -2.00 Mn
Dec 31, 2024 -2.00 Mn
Sep 30, 2024 -1.07 Mn
Sep 30, 2024 -1.07 Mn
Jun 30, 2024 -1.68 Mn
Jun 30, 2024 -1.68 Mn
Mar 31, 2024 -1.66 Mn
Mar 31, 2024 -1.66 Mn
Dec 31, 2023 -1.55 Mn
Dec 31, 2023 -1.55 Mn
Sep 30, 2023 -1.94 Mn
Sep 30, 2023 -1.94 Mn
Jun 30, 2023 -2.10 Mn
Jun 30, 2023 -2.10 Mn
Mar 31, 2023 -2.27 Mn
Mar 31, 2023 -2.27 Mn
Dec 31, 2022 -1.30 Mn
Dec 31, 2022 -1.30 Mn
Sep 30, 2022 -2.15 Mn
Sep 30, 2022 -2.15 Mn
Jun 30, 2022 -1.31 Mn
Jun 30, 2022 -1.31 Mn
Mar 31, 2022 -2.47 Mn
Mar 31, 2022 -2.47 Mn
Dec 31, 2021 -2.03 Mn
Dec 31, 2021 -2.03 Mn
Sep 30, 2021 -1.94 Mn
Sep 30, 2021 -1.94 Mn
Jun 30, 2021 -1.41 Mn
Jun 30, 2021 -1.41 Mn
Mar 31, 2021 -1.94 Mn
Mar 31, 2021 -1.94 Mn
Dec 31, 2020 -1.24 Mn
Dec 31, 2020 -1.24 Mn
Sep 30, 2020 -1.30 Mn
Sep 30, 2020 -1.30 Mn
Jun 30, 2020 -995,474.00
Jun 30, 2020 -995,474.00
Mar 31, 2020 -1.13 Mn
Mar 31, 2020 -1.13 Mn
Dec 31, 2019 -668,705.00
Dec 31, 2019 -668,705.00
Sep 30, 2019 -613,268.00
Sep 30, 2019 -613,268.00
Jun 30, 2019 -739,735.00
Jun 30, 2019 -739,735.00
Mar 31, 2019 -995,972.00
Mar 31, 2019 -995,972.00
Dec 31, 2018 -519,212.00
Dec 31, 2018 -519,212.00
Sep 30, 2018 -599,563.00
Sep 30, 2018 -599,563.00
Jun 30, 2018 -752,863.00
Jun 30, 2018 -752,863.00
Mar 31, 2018 -808,849.00
Mar 31, 2018 -808,849.00
Dec 31, 2017 -816,021.00
Dec 31, 2017 -816,021.00
Sep 30, 2017 -1.19 Mn
Sep 30, 2017 -1.19 Mn
Jun 30, 2017 -305,128.00
Jun 30, 2017 -305,128.00
Mar 31, 2017 -311,486.00
Mar 31, 2017 -311,486.00